ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / NTRB / forecast
CNXU (43) LAKE (26) AGPU (42) APT (61) ⌘ Pro Terminal →

Nutriband Inc. (NTRB) 12-Month Stock Forecast & Price Target Cone

$6.41 +1.75% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.42

Nutriband Inc. (NTRB) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $76.6M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NTRB Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $6.41 (+1.75% 1D, market cap $76.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #540 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NTRB compare to CNXU and LAKE in the Health Care sector?
▼

Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M) and LAKE (Lakeland Industries Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NTRB?
▼

Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $6.42 (+0.13%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510037
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D
Cash (4)Whales (10)SEC (11)Macro (9)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-9.5% Base Target
$10 Bull$6 Base$5 Bear
📬 FREE NTRB RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NTRB)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (37/100 Composite)
🔍 WHY NTRB SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Whale & Options Positioning+10/20 pts (27% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
45
Grade D$6.52-10.3% Next Q
Q2 (-2Q)
42
Grade D$5.85+1.7% Next Q
Q3 (-1Q)
40
Grade D$5.95+7.7% Next Q
Current
37
Grade D-$6.41-8.1% Hist 90D α
Trajectory: D (45) → D- (37)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NTRB Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NTRB currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.42) and Max Pain ($6.73) forces dealer call-delta covering toward $9.65.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NTRB• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NTRB Beats Next Quarter EPS Consensus (Jan 30, 2027) & Holds Above 200D SMA”
YES 37%NO 63%Trade / Inspect Odds →
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your NTRB Position Size: $10,000

Shares at $6.41: 1560.1 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $4.52
$7,051
$-2,949 (-29.5%)
12M Consensus BaseTarget $5.80
$9,048
$-952 (-9.5%)
12M Bull Case BreakoutTarget $9.65
$15,055
+$5,055 (+50.5%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 9
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$674%A
Goldman SachsSector Coverage LeadUNDERPERFORM$969%B
JP MorganUS Large-Cap ResearchSELL$558%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NTRB)

  • ✓Walkthrough of NTRB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
NTRB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +73.24%📐 HORIZONTAL RANGE
2026-11-03O $6.64H $6.64L $6.30C $6.41VOL 22.2K
RES: $11.00SUP: $2.60SMA50: $6.42SMA200: $4.39
$9.64$7.78$5.93$4.08$2.22RES $11.00SUP $2.60$6.412026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NTRB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NTRB Butterfly Map → + Track NTRB →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -4.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on NTRB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NTRB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NTRB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NTRB)

Health Care Rank #540 of 1016 ⚔️ CNXU vs NTRB Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NTRB vs. CNXU, LAKE, AGPU, APT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Nutriband Inc. (NTRB) ranks #540 by composite RQD confidence (37/100, grade D-) and #686 by equity capitalization ($76.6M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with NTRB at 37/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
NTRB ACTIVE
Nutriband Inc.
D- 37/100 — 27.8% -35.0% +1.75% $76.6M Benchmark Subject
CNXU
Conexeu Sciences Inc.
D- 43/100 — — — -5.51% $77.0M /cnxu-vs-ntrb →
LAKE
Lakeland Industries Inc.
E 26/100 — 32.9% -9.5% +1.82% $87.3M /lake-vs-ntrb →
AGPU
Axe Compute Inc.
D- 42/100 — — -35.0% -4.87% $92.7M /agpu-vs-ntrb →
APT
Alpha Pro Tech Ltd.
C- 61/100 16.2x 38.1% 6.7% +2.22% $55.1M /apt-vs-ntrb →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-01-31 • CIK 0001676047 ↗

In its most recent audited fiscal period (FY2025, filed 2026-01-31), Nutriband Inc. (NTRB) reported GAAP revenue of $2.0M (-4.8% vs. FY2024 revenue of $2.1M , and -2.3% cumulative change since FY2023) , GAAP net income of -$8.2M, operating cash flow of -$5.1M, and free cash flow of -$5.1M (-8.9% YoY). On the balance sheet, NTRB closed FY2025 with $7.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-01-31 $2.0M -$8.2M -$5.1M -$5.1M $7.5M —
FY2024 (FY) 2025-01-31 $2.1M -$10.5M -$4.6M -$4.7M $7.5M —
FY2023 (FY) 2024-01-31 $2.1M -$5.5M -$3.5M -$3.5M — —

3. NTRB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $6.41 (+1.75% 1D, market cap $76.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #540 in composite RQD confidence.

How does NTRB compare to CNXU and LAKE in the Health Care sector?

Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $77.0M) and LAKE (Lakeland Industries Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -9.5%, cap $87.3M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NTRB?

Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NTRB trading relative to its 50-day, 200-day, and 52-week technical levels?

NTRB last traded at $6.41 (+1.75% on volume of 14,755 shares), positioning the stock -0.16% below its 50-day simple moving average ($6.42) and +46.01% above its 200-day simple moving average ($4.39). Across its 52-week range of $2.80 to $9.19, NTRB sits at the 56.5% percentile with a 14-day RSI of 49.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($5.61 to $7.21).

Direct Sub-Reports: NTRB RQD Cockpit NTRB 12M Forecast NTRB Earnings & Move NTRB Dividends & DRIP NTRB Insiders & 13F NTRB Whale Options NTRB Profit Sankey NTRB News & Why
ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ SEC XBRL & RQD VERIFIED

NTRB — Nutriband Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-01-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Nutriband Inc. (NTRB) earns a live Roarable RQD composite score of 37/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $6.41 (+1.75% 1D, market capitalization $76.6M).

  • Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 27.8%, operating margin of -60.0%, and free cash flow yield of -6.37%.
  • Whale 13F & Options Flow (10/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (9/20) + Forensic Balance Sheet (11/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Nutriband Inc. (NTRB) is a NASDAQ-listed operating company in the Industrial Specialties industry (Health Care sector) with an equity market capitalization of $76.6M. The business operates with a gross margin of 27.8%, an operating margin of -60%, and a return on invested capital (ROIC) of -35% (free cash flow yield of -6.37%). Within the Industrial Specialties peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-01-31), Nutriband Inc. (NTRB) reported $2.0M in annual revenue (up from $2.1M in FY2024, -4.8% YoY) and -$8.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.1M revenue, -$5.5M net income) through FY2025, NTRB scaled operating cash flow to -$5.1M and free cash flow to -$5.1M, backed by $7.5M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 37/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -6.37% and institutional whale pillar of 10/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 10/20, sustained execution supports upside toward the upper end of the $2.80 – $9.19 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

No upstream or downstream dependencies, sector correlations, or second-order links are mapped in the source data.

  • Key Question #1: Can NTRB sustain or expand its -60.0% operating margin and -35.0% ROIC against Industrial Specialties peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $2.0M and free cash flow of -$5.1M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is NTRB's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

NTRB Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Nutriband Inc. (NTRB) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to NTRB Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NTRB Bull vs. Bear Conversation Board — What's Your Call at $6.41?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NTRB 🐻 33% BEARISH CONVICTION
1. Pick Your Side on NTRB:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $7.88 (+25.1%)
📌 Pinned Debate

Revenue has held near $2.0M–$2.1M across three periods while cash of $4.6M and a Piotroski F-Score of 4/9 show the balance sheet is not

Don't sleep on NTRB's setup in Health Care. Revenue has held near $2.0M–$2.1M across three periods while cash of $4.6M and a Piotroski F-Score of 4/9 show the balance sheet is not in acute distress.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (37/100) backs up the fundamental quality.

EarningsSniper 🐂 BULL

@ForensicBear Shorting a 10/20 institutional whale-flow stock at $6.30 is dangerous when funds are rotating into Health Care.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $4.72 (-25.1%)
Spot @ $6.30

Operating margin of -60% and ROIC of -35% with negative FCF of -$5.1M in FY 2025 show the business is consuming cash rather than genera

Sitting on the sidelines or leaning short NTRB above $6.30. Operating margin of -60% and ROIC of -35% with negative FCF of -$5.1M in FY 2025 show the business is consuming cash rather than generating returns.. Until Fundamental Cash Engine (4/20) and FCF yield (-6.37%) inflect higher, upside is capped near $9.19.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%